Mitral Valve Repair Reference Center at The Mount Sinai Hospital Mount Sinai

Click to view case study

OPERATION: Complex Barlow Mitral Valve Repair (P2 Resection with Detachment of P2 and Residual P1; Vertical and Horizontal Compression Followed by Sliding Plasty; Posterior Leaflet Flip to Correct A2 Prolapse and Reinforce P2 Repair; True Size 34 mm Carpentier-Edwards Physio II Ring)

Watch Video (Length: 8:09)

 

David H. Adams, MD, co-inventor of the next-generation Carpentier-Edwards Physio II mitral valve repair ring
David H. Adams, MD, co-inventor of the next-generation Carpentier-Edwards
Physio II mitral valve repair ring

New York, NY, February 23, 2009 -- David H. Adams, MD, Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, has performed the first two implantations of the Carpentier-Edwards Physio II ring in the United States. Dr. Adams co-invented the ring, which was cleared by the Food and Drug Administration last month, with Alain F. Carpentier, MD PhD, Chairman Emeritus of Cardiovascular Surgery at the Hôptial Europeen Georges Pompidou in Paris and Adjunct Professor of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center.

 

“We have learned a lot since Professor Carpentier invented the original Physio ring, and we are optimistic that the changes we made in the Physio II ring will result in a higher quality of valve repair in patients suffering from mitral valve disease,” said Dr. Adams.

 

The mitral valve lies between the left atrium and left ventricle of the heart. It prevents blood from leaking back into the left atrium during ejection (systole). Mitral valve regurgitation occurs when the valve does not close completely, and today the preferred treatment for such a condition is to repair the valve apparatus as opposed to replacing the valve with a metal or animal valve. Annuloplasty rings are specially designed to help restore the mitral valve to its normal size and shape (the valve is often enlarged or distorted in a diseased state.) If left untreated, mitral valve regurgitation can lead to debilitating symptoms including cardiac arrhythmia, congestive heart failure, and irreversible heart damage.

 

The first US Physio II implantation.
The first US Physio II implantation.

The new Carpentier-Edwards Physio II ring has many unique capabilities for mitral valve repair patients. “We can now use this ring to match the exact measurements and characteristics of a patient’s mitral valve like never before,” said Dr. Adams. The ring also features a sewing cuff that makes the device easier to implant.

 

 

 

 

Dr. Adams is the co-inventor of the Edwards Lifesciences' Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring and Carpentier-Edwards Physio II ring. Mount Sinai School of Medicine receives royalties from Edwards Lifesciences in connection with the sale of this product, but does not receive any royalties when the devices are implanted in patients at Mount Sinai.

 

Dr. Adams is the inventor of the Medtronic Tri-Ad™ Adams Tricuspid Annuloplasty Ring. Mount Sinai School of Medicine receives royalties from Medtronic in connection with the sale of this product, but does not receive any royalties when the device is implanted in patients at Mount Sinai. Dr. Adams is also National Co-Principal Investigator of the FDA Medtronic-CoreValve Pivotal Trial.

 

Page Created: Friday, 20 February 2009

Last Updated: Monday, 18 July 2011

 

Department of Cardiothoracic Surgery | The Mount Sinai Hospital | 1190 Fifth Avenue, Box 1028 | New York, NY  10029 | 866-MITRAL5 (648-7255)

Home | Site Map | The Mount Sinai Hospital | Press | About This Site | Legal Statement | Privacy Policy | Contact Us
Copyright © 2014, Icahn School of Medicine at Mount Sinai. All Rights Reserved. Site by Wang Media.

 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.